1. Home
  2. EVGN vs DKI Comparison

EVGN vs DKI Comparison

Compare EVGN & DKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • DKI
  • Stock Information
  • Founded
  • EVGN 1999
  • DKI 2018
  • Country
  • EVGN Israel
  • DKI Hong Kong
  • Employees
  • EVGN N/A
  • DKI N/A
  • Industry
  • EVGN Agricultural Chemicals
  • DKI
  • Sector
  • EVGN Industrials
  • DKI
  • Exchange
  • EVGN Nasdaq
  • DKI Nasdaq
  • Market Cap
  • EVGN 10.9M
  • DKI 11.9M
  • IPO Year
  • EVGN N/A
  • DKI 2025
  • Fundamental
  • Price
  • EVGN $1.31
  • DKI $0.66
  • Analyst Decision
  • EVGN Strong Buy
  • DKI
  • Analyst Count
  • EVGN 1
  • DKI 0
  • Target Price
  • EVGN $3.50
  • DKI N/A
  • AVG Volume (30 Days)
  • EVGN 150.4K
  • DKI 2.0M
  • Earning Date
  • EVGN 11-20-2025
  • DKI 11-11-2025
  • Dividend Yield
  • EVGN N/A
  • DKI N/A
  • EPS Growth
  • EVGN N/A
  • DKI N/A
  • EPS
  • EVGN N/A
  • DKI 26.19
  • Revenue
  • EVGN $9,444,000.00
  • DKI $10,204,329.00
  • Revenue This Year
  • EVGN N/A
  • DKI N/A
  • Revenue Next Year
  • EVGN $12.35
  • DKI N/A
  • P/E Ratio
  • EVGN N/A
  • DKI $0.03
  • Revenue Growth
  • EVGN 42.25
  • DKI 100.46
  • 52 Week Low
  • EVGN $0.95
  • DKI $0.60
  • 52 Week High
  • EVGN $2.87
  • DKI $15.00
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 54.40
  • DKI N/A
  • Support Level
  • EVGN $1.21
  • DKI N/A
  • Resistance Level
  • EVGN $1.32
  • DKI N/A
  • Average True Range (ATR)
  • EVGN 0.08
  • DKI 0.00
  • MACD
  • EVGN -0.00
  • DKI 0.00
  • Stochastic Oscillator
  • EVGN 36.03
  • DKI 0.00

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

About DKI DarkIris Inc. Class A Ordinary Shares

Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.

Share on Social Networks: